Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells.
Bone Marrow Transplant. 1999 Feb;23(4):311-5. doi: 10.1038/sj.bmt.1701589.
Bone Marrow Transplant. 1999.
PMID: 10100573
Clinical Trial.
Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting.
Burtness B, Windsor S, Holston B, DiStasio S, Staugaard-Hahn C, Abrantes J, Kneuper-Hall R, Farber L, Orell J, Bober-Sorcinelli K, Haffty BG, Reiss M.
Burtness B, et al. Among authors: staugaard hahn c.
Cancer J Sci Am. 1999 Jul-Aug;5(4):224-9.
Cancer J Sci Am. 1999.
PMID: 10439168
Clinical Trial.
Item in Clipboard
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancer.
Bou-Khalil J, Rose M, Psyrri A, D'Andrea E, Medoff E, Staugaard-Hahn C, Holtkamp C, Gran S, Pezzimente J, Snyder E, Cooper D, Haffty B, Reiss M, Burtness B.
Bou-Khalil J, et al. Among authors: staugaard hahn c.
Breast J. 2003 Nov-Dec;9(6):472-7. doi: 10.1046/j.1524-4741.2003.09604.x.
Breast J. 2003.
PMID: 14616941
Item in Clipboard
Cite
Cite